Preprint Essay Version 1 Preserved in Portico This version is not peer-reviewed

Zoonotic Risk Technology Enters the Viral Emergence Toolkit

Version 1 : Received: 6 April 2021 / Approved: 7 April 2021 / Online: 7 April 2021 (11:53:59 CEST)

How to cite: Carlson, C.; Farrell, M.; Grange, Z.; Han, B.; Mollentze, N.; Phelan, A.; Rasmussen, A.; Albery, G.; Bett, B.; Brett-Major, D.; Cohen, L.; Dallas, T.; Eskew, E.; Fagre, A.; Forbes, K.; Gibb, R.; Halabi, S.; Hammer, C.; Katz, R.; Kindrachuk, J.; Muylaert, R.; Nutter, F.; Ogola, J.; Olival, K.; Rourke, M.; Ryan, S.; Ross, N.; Seifert, S.; Sironen, T.; Standley, C.; Taylor, K.; Venter, M.; Webala, P. Zoonotic Risk Technology Enters the Viral Emergence Toolkit. Preprints 2021, 2021040200. https://doi.org/10.20944/preprints202104.0200.v1 Carlson, C.; Farrell, M.; Grange, Z.; Han, B.; Mollentze, N.; Phelan, A.; Rasmussen, A.; Albery, G.; Bett, B.; Brett-Major, D.; Cohen, L.; Dallas, T.; Eskew, E.; Fagre, A.; Forbes, K.; Gibb, R.; Halabi, S.; Hammer, C.; Katz, R.; Kindrachuk, J.; Muylaert, R.; Nutter, F.; Ogola, J.; Olival, K.; Rourke, M.; Ryan, S.; Ross, N.; Seifert, S.; Sironen, T.; Standley, C.; Taylor, K.; Venter, M.; Webala, P. Zoonotic Risk Technology Enters the Viral Emergence Toolkit. Preprints 2021, 2021040200. https://doi.org/10.20944/preprints202104.0200.v1

Abstract

In light of the urgency raised by the COVID-19 pandemic, global investment in wildlife virology is likely to increase, and new surveillance programs will identify hundreds of novel viruses that might someday pose a threat to humans. Our capacity to identify which viruses are capable of zoonotic emergence depends on the existence of a technology—a machine learning model or other informatic system—that leverages available data on known zoonoses to identify which animal pathogens could someday pose a threat to global health. We synthesize the findings of an interdisciplinary workshop on zoonotic risk technologies to answer the following questions: What are the prerequisites, in terms of open data, equity, and interdisciplinary collaboration, to the development and application of those tools? What effect could the technology have on global health? Who would control that technology, who would have access to it, and who would benefit from it? Would it improve pandemic prevention? Could it create new challenges?

Keywords

zoonotic risk; viral emergence; viral ecology; genomics; machine learning; access and benefit sharing; intellectual property law; global health

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.